Anavex Life Sciences (AVXL) Operating Expenses (2016 - 2026)
Anavex Life Sciences (AVXL) recorded Operating Expenses of -$6.74 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with $14.46 million a year earlier.
Anavex Life Sciences (AVXL) Operating Expenses (2016 - 2026) Analysis & Trends
On a TTM basis, Anavex Life Sciences' Operating Expenses came in at $17.37 million as of Jun 30, 2026, down 68.3% year-over-year; for FY2025 (ended Sep 30, 2025), it came in at $51.41 million, down 2.8% from FY2024.
- Across earlier fiscal years, Operating Expenses came in at $52.88 million in FY2024 (-5.2%), $55.76 million in FY2023 (+9.4%), $50.99 million in FY2022 (+21.4%) and $42 million in FY2021.
- The fiscal Q3 2026 figure is the lowest quarterly Operating Expenses since fiscal Q4 2020.
- On a year-over-year basis, Operating Expenses rose in two of the last seven quarters, with an average decline of 13.1%.
- Peak year-over-year performance for Operating Expenses in the last five years was growth of 31.2% in fiscal Q1 2023, against a decline of 50.1% in fiscal Q1 2026 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $6.48 million (Q2 2026), $6.78 million (Q1 2026) and $10.84 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.12 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 10.56 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 12.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -6.09 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -9.70 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 6.54 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 18.20 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 6.68 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 2.09 Bn |
| 10 | Anavex Life Sciences | 187.25 Mn | -292.83 Mn | - | -6.74 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.74 Mn |
| Mar 31, 2026 | 6.48 Mn |
| Dec 31, 2025 | 6.78 Mn |
| Sep 30, 2025 | 10.84 Mn |
| Jun 30, 2025 | 14.46 Mn |
| Mar 31, 2025 | 12.51 Mn |
| Dec 31, 2024 | 13.59 Mn |
| Sep 30, 2024 | 14.27 Mn |
| Jun 30, 2024 | 14.60 Mn |
| Mar 31, 2024 | 12.62 Mn |
| Dec 31, 2023 | 11.38 Mn |
| Sep 30, 2023 | 12.66 Mn |
| Jun 30, 2023 | 13.53 Mn |
| Mar 31, 2023 | 14.19 Mn |
| Dec 31, 2022 | 15.38 Mn |
| Sep 30, 2022 | 15.28 Mn |
| Jun 30, 2022 | 12.46 Mn |
| Mar 31, 2022 | 11.52 Mn |
| Dec 31, 2021 | 11.72 Mn |
| Sep 30, 2021 | 12.25 Mn |
Anavex Life Sciences Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-expenses&ticker=AVXL&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-expenses", "ticker": "AVXL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=operating-expenses&ticker=AVXL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();